Acne

Energy-based treatments can be used on their own or in conjunction with medical treatments to address chronic dermatological conditions like melasma, acne, and vitiligo.

Cumulative dosing of isotretinoin has followed a reference range of 120 to 150 mg/kg, but there is an absence of strong evidence supporting this recommendation, pointing to the need for clinicians to treat their patients to achieve clearance of acne rather than adhere to this range.

An expert goes over the pros and cons of some of the available OTC acne products.

An expert discusses which types of products tend to be more comdedogenic and acnegenic.

An expert discusses available types of facial foundations and their effect on the skin in regards to acne.

Pediatric atopic dermatitis and acne have some similarities when these present in skin of color and lighter-skin children. But there are important differences when these common skin conditions affect darker skin types. An expert discusses how treatments should be approached.

Dividing the pediatric population into three age groups helps streamline effective treatment for acne.

Evidence is mounting for the use of probiotics, prebiotics and microbial lysates in skincare. One expert examines the literature and shares observations.

Facial care advice for patients with acneWhile both benzoyl peroxide acne preparations and vitamin C products carry benefits in acne treatment, it’s wise to recall the characteristics of each element in advising patients on caring for their skin. Vitamin C is rapidly oxidized with exposure to air. Benzoyl peroxide is an oxidant. This is how Dr. Draelos suggests these products be used.

Data suggest photodynamic therapy with the investigational topical methyl aminolevulinate may be an effective treatment for patients with severe facial acne.

Results from three phase 3 trials, suggest ixekizumab (Talz, Eli Lilly & Company) is effective through 60 weeks of treatment among patients with moderate-to-severe plaque psoriasis.

The acne app offers a free and immediate analysis of acne type and severity; develops an individualized acne control plan; and monitors users’ progress. It aims to help consumers diagnose, treat, manage and prevent acne.

Researchers report on survey findings that shed light on why patients find acne consultations ineffective.

Researchers reveal that patients may have concerns with acne consultations. The authors offer tips to improve acne consults.

Acne presents with certain nuances in darker skin patients. Exacerbating factors, treatment approaches and desired treatment outcomes may differ from lighter skin patients.

The investigational sebum-inhibiting topical DRM01 had positive results in a phase 2b study, which paves the way for phase 3 trials planned for 2017.

GlobalMed has represented medical and aesthetic dermatology brands, including BMT, CoolTouch and Radiancy, since 1996. Omnilux noninvasively treats dermatologic conditions, including acne, fine lines and wrinkles and non-melanoma skin cancer.

A growing number of studies suggest diet influences general skin health and specific skin diseases, from acne and eczema to skin aging. Dermatologists share their best practices for using diet to combat skin disease and promote skin health.

Two novel energy-based approaches are ushering in a new era in acne treatment. One expert addresses the role these devices may play.

While oral isotretinoin has been associated with various side effects and routine blood tests have been recommended, evidence points to inconsistencies in monitoring practices. Many physicians also are questioning whether the effort has value.

Experts discuss association between inflammasomes and acne that may lead to treatments stopping acne before clinical signs emerge.

While many are in early phase studies, most of the new topical options are targeting sebum reduction, a novel pathway to controlling acne, and the data are exciting, one expert says.

New findings support dietary and supplementation practices that can influence acne. One expert discusses modifications in context of protocols for managing the condition.

The AAD’s new guidelines for the care and management of acne vulgaris include several updates for dermatologists, including an increased emphasis on oral antibiotic stewardship and recommendations for use.

Allergan announced in late February that the FDA approved its topical Aczone (dapsone) Gel, 7.5% for treatment of acne vulgaris.